Participants 77 132 4
hyperphosphatemic patients with end-stage renal disease
Participants 193 240 5
patients receiving long-term dialysis treatment
Participants 377 421 4
patients with end-stage renal disease (ESRD)
Participants 585 611 3
Chinese patients with ESRD
Participants 749 786 3
male and female hemodialysis patients
